CompletedPhase 4NCT03762824

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease

Studying Systemic lupus erythematosus

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Region Skane
Principal Investigator
Jehns Martineus, MD, M.D
Skåne Universitets sjukhus, dept of rheumatology
Intervention
13-valent pneumococcal conjugate vaccine(biological)
Enrollment
300 enrolled
Eligibility
18 years · All sexes
Timeline
20162020

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03762824 on ClinicalTrials.gov

Other trials for Systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Systemic lupus erythematosus

← Back to all trials